Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Praxis Precision Medicines (PRAX) Income from Continuing Operations (2022 - 2025)

Praxis Precision Medicines (PRAX) has 4 years of Income from Continuing Operations data on record, last reported at 97044000.0 in Q4 2025.

  • For Q4 2025, Income from Continuing Operations fell 51.74% year-over-year to 97044000.0; the TTM value through Dec 2025 reached 326198000.0, down 62.96%, while the annual FY2025 figure was 326198000.0, 62.96% down from the prior year.
  • Income from Continuing Operations reached 97044000.0 in Q4 2025 per PRAX's latest filing, down from 78359000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 25516000.0 in Q3 2023 and bottomed at 97044000.0 in Q4 2025.
  • Average Income from Continuing Operations over 4 years is 54211062.5, with a median of 50390000.0 recorded in 2022.
  • Peak YoY movement for Income from Continuing Operations: soared 44.67% in 2023, then plummeted 130.01% in 2024.
  • A 4-year view of Income from Continuing Operations shows it stood at 41453000.0 in 2022, then soared by 32.92% to 27806000.0 in 2023, then tumbled by 130.01% to 63956000.0 in 2024, then plummeted by 51.74% to 97044000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Income from Continuing Operations were 97044000.0 in Q4 2025, 78359000.0 in Q3 2025, and 76067000.0 in Q2 2025.